S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in

Canopy Growth Stock Forecast, Price & News

-2.01 (-5.70 %)
(As of 03/3/2021 12:00 AM ET)
Today's Range
Now: $33.24
50-Day Range
MA: $37.83
52-Week Range
Now: $33.24
Volume4.99 million shs
Average Volume8.58 million shs
Market Capitalization$12.49 billion
P/E RatioN/A
Dividend YieldN/A
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Canopy Growth logo


Canopy Growth May Go Higher and Still Not Be a Buy
February 8, 2021 |  marketbeat.com
Why Canopy Growth Stock Rose Today
March 2, 2021 |  msn.com
Canopy Growth vs Tilray: How Do They Compete?
March 2, 2021 |  finance.yahoo.com
The SEC Finally Says Enough to One Social Media-Fueled Trade
February 12, 2021 |  finance.yahoo.com
Pot Stocks Are Getting Crushed. What You Need to Know.
February 11, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolNASDAQ:CGC
Phone855 558 9333
Year FoundedN/A



Sales & Book Value

Annual Sales$297.34 million
Cash Flow$1.57 per share
Book Value$10.97 per share


Net Income$-993,370,000.00
Net Margins-312.84%


Market Cap$12.49 billion
Next Earnings Date6/4/2021 (Estimated)


Overall MarketRank

0.85 out of 5 stars

Medical Sector

1119th out of 1,968 stocks

Medicinals & Botanicals Industry

10th out of 33 stocks

Analyst Opinion: 3.0Community Rank: 1.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-2.01 (-5.70 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

Is Canopy Growth a buy right now?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 5 sell ratings, 10 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view top-rated stocks.

What stocks does MarketBeat like better than Canopy Growth?

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Canopy Growth?

Canopy Growth saw a decrease in short interest in February. As of February 12th, there was short interest totaling 11,950,000 shares, a decrease of 45.8% from the January 28th total of 22,040,000 shares. Based on an average daily volume of 7,050,000 shares, the short-interest ratio is presently 1.7 days. Approximately 5.2% of the company's stock are sold short.
View Canopy Growth's Short Interest

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, June 4th 2021.
View our earnings forecast for Canopy Growth

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) released its quarterly earnings results on Monday, February, 8th. The company reported ($2.43) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.21) by $2.22. The company had revenue of $153 million for the quarter, compared to analysts' expectations of $149.94 million. Canopy Growth had a negative net margin of 312.84% and a negative trailing twelve-month return on equity of 13.11%. The firm's revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the firm earned ($0.35) EPS.
View Canopy Growth's earnings history

How has Canopy Growth's stock price been impacted by Coronavirus (COVID-19)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CGC shares have increased by 149.0% and is now trading at $33.24.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CGC?

20 brokerages have issued 1-year price targets for Canopy Growth's stock. Their forecasts range from $21.10 to $64.00. On average, they expect Canopy Growth's share price to reach $38.57 in the next year. This suggests a possible upside of 16.0% from the stock's current price.
View analysts' price targets for Canopy Growth
or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. David Eric Klein, CEO & Director (Age 57, Pay $2.23M)
  • Mr. Rade Nikola Kovacevic, Pres & Chief Product Officer (Age 35, Pay $642.6k)
  • Mr. Michael Alan Lee, Exec. VP & CFO (Age 48, Pay $824.95k)
  • Mr. Thomas Carlton Stewart, VP & Chief Accounting Officer (Age 39, Pay $344.36k)
  • Mr. Phillip Stephen Shaer, Chief Legal Officer (Age 47, Pay $267.83k)
  • Mr. Timothy Rob Saunders, Strategic Advisor (Age 60, Pay $328.43k)
  • Mr. Andrew MacCorquodale, COO & VP of Operations Transformation
  • Mr. Thomas Shipley IV, Sr. VP of Quality Assurance & Chief Science Officer (Age 32)
  • Ms. Holly Lukavsky, Chief HR Officer
  • Jason Green, Head of Agriculture - Hemp Division

Who are some of Canopy Growth's key competitors?

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by many different institutional and retail investors. Top institutional investors include ETF Managers Group LLC (0.79%), Morgan Stanley (0.43%), The Manufacturers Life Insurance Company (0.29%), Swiss National Bank (0.24%), Voloridge Investment Management LLC (0.23%) and Toronto Dominion Bank (0.19%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth

Which institutional investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including CIBC World Markets Inc., Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Swiss National Bank, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Dimensional Fund Advisors LP, Public Sector Pension Investment Board, and Bank of New York Mellon Corp. Company insiders that have sold Canopy Growth company stock in the last year include Phillip Stephen Shaer, Rade Nikola Kovacevic, and Tomas Iv Shipley.
View insider buying and selling activity for Canopy Growth
or view top insider-selling stocks.

Which institutional investors are buying Canopy Growth stock?

CGC stock was purchased by a variety of institutional investors in the last quarter, including Voloridge Investment Management LLC, ETF Managers Group LLC, Maple Rock Capital Partners Inc., Credit Suisse AG, LPL Financial LLC, CIBC Asset Management Inc, Renaissance Technologies LLC, and State of Wisconsin Investment Board.
View insider buying and selling activity for Canopy Growth
or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $33.24.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of $12.49 billion and generates $297.34 million in revenue each year. The company earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis.

How many employees does Canopy Growth have?

Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

Where are Canopy Growth's headquarters?

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at 855 558 9333 or via email at [email protected]

This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.